We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$256M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$156M |
| 4 |
Franco-Nevada
FNV
|
+$115M |
| 5 |
NVIDIA
NVDA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Pfizer
PFE
|
+$226M |
| 3 |
Amazon
AMZN
|
+$224M |
| 4 |
Johnson & Johnson
JNJ
|
+$220M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 19.43% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Aecom
ACM
$9.65B
| $703K | ﹤0.01% |
+8,339
| New | +$719K |
|
1202
Cleveland-Cliffs
CLF
$6.83B
| $702K | ﹤0.01% |
38,300
-600
| -2% | -$11.9K |
|
|
NVRO
1203
DELISTED
NEVRO CORP.
NVRO
| $701K | ﹤0.01% |
19,390
+3,100
| +19% | +$109K |
|
1204
Customers Bancorp
CUBI
$2.81B
| $700K | ﹤0.01% |
37,800
+8,100
| +27% | +$221K |
|
1205
Kearny Financial
KRNY
$615M
| $700K | ﹤0.01% |
86,212
| – | – |
|
1206
Medifast
MED
$146M
| $695K | ﹤0.01% |
6,700
+2,900
| +76% | +$321K |
|
|
SWN
1207
DELISTED
Southwestern Energy Company
SWN
| $690K | ﹤0.01% |
+138,082
| New | +$732K |
|
1208
Green Dot
GDOT
$757M
| $689K | ﹤0.01% |
40,100
+15,000
| +60% | +$262K |
|
1209
Rocket Pharmaceuticals
RCKT
$378M
| $684K | ﹤0.01% |
39,915
-2,300
| -5% | -$45K |
|
1210
REX American Resources
REX
$1.44B
| $675K | ﹤0.01% |
47,200
+23,200
| +97% | +$367K |
|
1211
Knight Transportation
KNX
$11.6B
| $669K | ﹤0.01% |
11,818
+86
| +0.7% | +$4.92K |
|
1212
Protagonist Therapeutics
PTGX
$8.61B
| $667K | ﹤0.01% |
+29,000
| New | +$487K |
|
|
PSPC.U
1213
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
| $660K | ﹤0.01% |
64,680
| – | – |
|
|
GMS
1214
DELISTED
GMS Inc
GMS
| $648K | ﹤0.01% |
11,200
+4,300
| +62% | +$244K |
|
1215
Lincoln National
LNC
$8.95B
| $643K | ﹤0.01% |
28,616
-11,781
| -29% | -$350K |
|
|
DCPH
1216
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $637K | ﹤0.01% |
41,200
-2,200
| -5% | -$36.7K |
|
1217
HEICO Corp Class A
HEI.A
$37B
| $631K | ﹤0.01% |
4,646
-116
| -2% | -$15.4K |
|
1218
Adaptive Biotechnologies
ADPT
$3.78B
| $631K | ﹤0.01% |
71,485
-19,634
| -22% | -$173K |
|
1219
Aramark
ARMK
$14.8B
| $630K | ﹤0.01% |
24,380
+277
| +1% | +$7.88K |
|
1220
Upwork
UPWK
$1.16B
| $627K | ﹤0.01% |
55,380
| – | – |
|
1221
Futu Holdings
FUTU
$15.4B
| $620K | ﹤0.01% |
11,967
-317
| -3% | -$15.4K |
|
|
CHS
1222
DELISTED
Chicos FAS, Inc.
CHS
| $615K | ﹤0.01% |
111,900
+46,000
| +70% | +$245K |
|
1223
Movado Group
MOV
$874M
| $613K | ﹤0.01% |
21,300
+8,900
| +72% | +$302K |
|
|
DCBO
1224
Docebo
DCBO
$525M
| $612K | ﹤0.01% |
15,051
+1,194
| +9% | +$43.9K |
|
|
DISH
1225
DELISTED
DISH Network Corp.
DISH
| $611K | ﹤0.01% |
65,469
+123
| +0.2% | +$1.55K |
|
Similar funds
VAM
TD Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.
- TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
- TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
- TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
- TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
- TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
- TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
- TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.